SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry

BACKGROUND: There is a lack of data on SARS-CoV-2 vaccination safety in children and young people (CYP) with rheumatic and musculoskeletal diseases (RMDs). Current vaccination guidance is based on data from adults with RMDs or CYP without RMDs. OBJECTIVES: To describe the safety of SARS-COV-2 vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawson-Tovey, Saskia, Machado, Pedro M, Strangfeld, Anja, Mateus, Elsa, Gossec, Laure, Carmona, Loreto, Raffeiner, Bernd, Bulina, Inita, Clemente, Daniel, Zepa, Julija, Rodrigues, Ana M., Mariette, Xavier, Hyrich, Kimme L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344592/
https://www.ncbi.nlm.nih.gov/pubmed/35908834
http://dx.doi.org/10.1136/rmdopen-2022-002322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344592/
https://www.ncbi.nlm.nih.gov/pubmed/35908834
http://dx.doi.org/10.1136/rmdopen-2022-002322

Ejemplares similares